ADARx Pharmaceuticals
San Diego, United States· Est.
ADARx Pharmaceuticals is developing RNA-targeting therapies and editing platforms to treat genetic diseases by modulating RNA function.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $246M
About
ADARx Pharmaceuticals is developing RNA-targeting therapies and editing platforms to treat genetic diseases by modulating RNA function.
RNA TherapeuticsGenetics & GenomicsRare Disease
Funding History
2Total raised:$246M
PIPE$200M
Series B$46M